Home > Riviste > Italian Journal of Dermatology and Venereology > Fascicoli precedenti > Articles online first > Giornale Italiano di Dermatologia e Venereologia 2020 Oct 16

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

 

Giornale Italiano di Dermatologia e Venereologia 2020 Oct 16

DOI: 10.23736/S0392-0488.20.06632-8

Copyright © 2020 EDIZIONI MINERVA MEDICA

lingua: Inglese

A retrospective study on clinical subtypes and management of morphea in 10 Italian Dermatological Units

Annalucia VIRDI 1 , Annalisa PATRIZI 1, Stefano CAMBIAGHI 2, Andrea DIOCIAIUTI 3, Maya EL HACHEM 3, Donatella SCHENA 4, Andrea BASSI 5, Domenico BONAMONTE 6, Valeria BRAZZELLI 7, Anna BELLONI FORTINA 8, Patrizia PEPE 9, Vito DI LERNIA 10, Iria NERI 1

1 Division of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi
Hospital, University of Bologna, Bologna, Italy; 2 Pediatric Dermatology Unit, Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico di Milano, University of Milan, Milan, Italy; 3 Dermatology Division, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy; 4 Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy; 5 Pediatric Dermatology Service, Anna Meyer Pediatric Hospital, Florence, Italy; 6 Section of Dermatology, Department of Biomedical Science and Human Oncology, University of Bari, Bari, Italy; 7 Department of Clinical-Surgical, Diagnostic and Pediatric Science, Institute of Dermatology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy; 8 Pediatric Dermatology Unit, Department of Medicine, University of Padua, Padua, Italy; 9 Dermatology Unit, Surgical, Medical and Dental Department of Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy; 10 Dermatology Unit, Arcispedale S. Maria Nuova IRCCS, Reggio Emilia, Italy


PDF


BACKGROUND: There are still few dermatological studies on morphea. We evaluated the epidemiological and clinical features and management of pediatric morphea, reporting dermatologists experience.
METHODS: A multicentre retrospective observational study was carried out on the epidemiological and clinical features and management of the disease between 01/01/2009 and 01/10/2014 in 10 Italian Dermatological Units.
RESULTS: We collected the data of 69 children affected by: circumscribed morphea (39.1%); linear morphea of trunk and limbs (14.5%); en coupe de sabre morphea (ECDS) (14.5%); progressive facial hemiatrophy (8.7%); generalized form (18.8%); mixed morphea (4.4%). The mean age at onset was 6.86±3.21 years, mainly between 2 and 8 years, but is statistically significantly lower for ECDS (4.5±3.03). Localizations were: head/neck (30.4%), limbs (26.1%), trunk (14.5%), 2 or more sites (29%), most often the trunk plus limbs. Extracutaneous manifestations were observed in 26.1% patients. 10 patients presented a second autoimmune disorder. Treatments were topical in 26.1% cases and systemic (alone or associated with topical treatments) in 68.1%.
CONCLUSIONS: There was a lack of uniformity in the management of patients and an increasing awareness of dermatologists on the use of systemic therapies, in particular of methotrexate, which is no longer exclusive to rheumatologists. Methotrexate causes stabilization and improvement of the clinical signs, but topical creams are still considered adjuvant or maintenance therapies during/after the use of systemic drugs.


KEY WORDS: Pediatric morphea; Morpheajuvenile localized scleroderma; Dermatologist

inizio pagina